Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Role of Novel RADA16 Hydrogel in Endoscopic Skull Base Surgery

NCT: NCT05898074 · RECRUITING

NCT IDNCT05898074
StatusRECRUITING
Start Date2023-10-09
Completion2027-02-15
SponsorIndiana University (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to specifically evaluate the effectiveness of PuraGel, a RADA16 polypeptide hydrogel, in expediting post-operative healing and re-mucosalization of the nasoseptal flap harvest site during endoscopic skull base surgery and the impact on patient and sinonasal morbidity.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑